Success Story: NIW Approved in 8 Days under Premium Processing for an Oncologic Surgery Physician Advancing Robotic Minimally Invasive Care

 

Client’s Testimonial:

"Thank you very much for all your help and guidance throughout this process — I truly appreciate it.”

---

On February 17^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Fellow in the Field of Surgery (Approval Notice).

---

General Field: Oncologic Surgery

Position at the Time of Case Filing: Fellow

State of Residence at the Time of Filing: New York

Approval Notice Date: February 17^th, 2026

Processing Time: 8 days (Premium Processing Requested)

---

Case Summary:  

An EB-2 NIW petition, filed with Premium Processing from the outset, was approved in just 8 days for the client, a physician-researcher whose work strengthens evidence-based minimally invasive surgery, with a particular emphasis on robotic techniques that can improve cancer outcomes, reduce complications, and expand access to advanced surgical care.

Research Leadership and National Impact

The client holds an M.B.B.S. and is currently employed in the United States in a research-focused clinical role within oncologic surgery, while also conducting ongoing research at a U.S. academic medical center. As an expert in oncologic surgery, the client’s proposed endeavor is to continue investigating minimally invasive oncologic surgery, emphasizing robotic surgical techniques, through clinical research and clinical trials to generate scalable, evidence-based surgical strategies applicable across diverse U.S. healthcare systems.

We demonstrated that this endeavor is an area of clear substantial merit and national importance because it targets practical, measurable improvements in surgical safety, recovery, and long-term outcomes for patients undergoing complex cancer care. Rather than relying on broad statements about robotics, the petition emphasized how multicenter evidence and outcomes-based research can guide safer adoption, improve patient selection and perioperative planning, and help reduce preventable complications, especially for high-risk and underserved populations.

Impressive Credentials and Achievements

To support that the client is well positioned to advance the endeavor, we documented objective indicators of productivity and independent reliance, while also explaining how an adjudicator would likely interpret them:

• 14 peer-reviewed journal articles (2 first-authored), 5 abstracts (1 first-authored), and a continued trajectory of clinically relevant research output
• 41 citations to the client’s published body of work, presented as evidence of independent reliance rather than a numbers-only claim
• Competitive research support connected to a major funding source that supports cancer-focused innovation, reinforcing the practical value and credibility of the client’s research direction

We explained that, in clinical research, influence is best demonstrated when other researchers rely on the work to guide their own studies and recommendations. We also provided context by highlighting that several publications achieved strong field-and-year citation percentile performance, which helps adjudicators interpret impact in a normalized way rather than focusing only on raw citation totals.

NIW Approval and Outlook

USCIS approved the client’s NIW petition in 8 days under Premium Processing. This approval reflects a clear showing that the endeavor has substantial merit and national importance and that the client is well-positioned to advance it through peer-reviewed scholarship, documented independent reliance, and credible research support. We look forward to the client’s continued contributions to scalable, evidence-based robotic urologic surgery strategies that improve cancer care quality and access across the United States.